HY-17518A-10mg
|
MedChemexpress LLC
|
(S,S)-Valifenalate [CAS 283159-94-4]
|
|
Neuroscience-Neuromodulation
|
|
HY-17518A-25mg
|
MedChemexpress LLC
|
(S,S)-Valifenalate [CAS 283159-94-4]
|
|
Neuroscience-Neuromodulation
|
|
HY-17518A-5mg
|
MedChemexpress LLC
|
(S,S)-Valifenalate [CAS 283159-94-4]
|
|
Neuroscience-Neuromodulation
|
|
HY-17518A-50mg
|
MedChemexpress LLC
|
(S,S)-Valifenalate [CAS 283159-94-4]
|
|
Neuroscience-Neuromodulation
|
|
HY-17518A-1mL
|
MedChemexpress LLC
|
(S,S)-Valifenalate [CAS 283159-94-4] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
HY-13212-10mg
|
MedChemexpress LLC
|
(Z)-2-Decenoic acid [CAS 15790-91-7]
|
|
Cancer-programmed cell death
|
|
HY-13212-5mg
|
MedChemexpress LLC
|
(Z)-2-Decenoic acid [CAS 15790-91-7]
|
|
Cancer-programmed cell death
|
|
HY-13212-1mL
|
MedChemexpress LLC
|
(Z)-2-Decenoic acid [CAS 15790-91-7] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-B1005-100mg
|
MedChemexpress LLC
|
8-Hydroxyquinoline [CAS 148-24-3]
|
|
Cancer-programmed cell death
|
|
HY-B1005-1mL
|
MedChemexpress LLC
|
8-Hydroxyquinoline [CAS 148-24-3] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-P71685-10ug
|
MedChemexpress LLC
|
ABL1, Human (GST)
|
|
|
|
HY-P71685-5ug
|
MedChemexpress LLC
|
ABL1, Human (GST)
|
|
|
|
HY-P71685-50ug
|
MedChemexpress LLC
|
ABL1, Human (GST)
|
|
|
|
HY-15491-10mg
|
MedChemexpress LLC
|
AG-024322 [CAS 837364-57-5]
|
|
Cancer-Kinase/protease
|
|
HY-15491-25mg
|
MedChemexpress LLC
|
AG-024322 [CAS 837364-57-5]
|
|
Cancer-Kinase/protease
|
|
HY-15491-5mg
|
MedChemexpress LLC
|
AG-024322 [CAS 837364-57-5]
|
|
Cancer-Kinase/protease
|
|
HY-15491-50mg
|
MedChemexpress LLC
|
AG-024322 [CAS 837364-57-5]
|
|
Cancer-Kinase/protease
|
|
HY-15491-1mL
|
MedChemexpress LLC
|
AG-024322 [CAS 837364-57-5] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
HY-120836-10mg
|
MedChemexpress LLC
|
AOH1160 [CAS 2089314-57-6]
|
|
Cancer-programmed cell death
|
|
HY-120836-100mg
|
MedChemexpress LLC
|
AOH1160 [CAS 2089314-57-6]
|
|
Cancer-programmed cell death
|
|
HY-120836-25mg
|
MedChemexpress LLC
|
AOH1160 [CAS 2089314-57-6]
|
|
Cancer-programmed cell death
|
|
HY-120836-5mg
|
MedChemexpress LLC
|
AOH1160 [CAS 2089314-57-6]
|
|
Cancer-programmed cell death
|
|
HY-120836-50mg
|
MedChemexpress LLC
|
AOH1160 [CAS 2089314-57-6]
|
|
Cancer-programmed cell death
|
|
HY-136521-10mg
|
MedChemexpress LLC
|
AZ13824374
|
|
Cancer-programmed cell death
|
|
HY-136521-2mg
|
MedChemexpress LLC
|
AZ13824374
|
|
Cancer-programmed cell death
|
|